BNT111
Showing 1 - 20 of 20
Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma Trial in Worldwide (BNT111, Cemiplimab)
Recruiting
- Melanoma Stage III
- +2 more
- BNT111
- Cemiplimab
-
Tucson, Arizona
- +53 more
Aug 24, 2022
Melanoma Trial in Germany (Lipo-MERIT)
Active, not recruiting
- Melanoma
- Lipo-MERIT
-
Frankfurt, Germany
- +3 more
Jan 5, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Sumida-ku, Fukuoka (BNT162b2, Placebo)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- Placebo
-
Sumida-ku, Tokyo, Japan
- +1 more
Jan 13, 2023
Profiling Spike Protein Antibody Response Post COVID Booster
Not yet recruiting
- SARS-CoV-2 Booster
- Spike Protein IgG Antibody
- Obtain antibody titers
- (no location specified)
Jul 25, 2022
SARS-CoV-2 Trial in Beijing (Probiotics daily, Placebo daily)
Completed
- SARS-CoV-2
- Probiotics daily
- Placebo daily
-
Beijing, China
- +1 more
Jul 3, 2022
SARS-CoV-2 Trial in Beijing (1 week (Week 1), 1 week of probiotics(Week 1), 1 week (Week 2))
Recruiting
- SARS-CoV-2
- 1 week placebo(Week 1)
- +5 more
-
Beijing, China
- +1 more
Jul 3, 2022
Immunity Against COVID-19 Vaccine in Healthcare Workers in
Active, not recruiting
- Coronavirus 2019
- +2 more
- Immunoglobulin G detection
-
Buenos Aires, Caba, ArgentinaHospital Italiano de Buenos Aires
Aug 1, 2022
COVID-19 Vaccines in Patients Undergoing Immunotherapy for
Recruiting
- Cancer
- Immunotherapy
-
Albi, France
- +12 more
Jan 17, 2022
COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,
Recruiting
- COVID-19 Pandemic
- COVID-19 Vaccines
- Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
- CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
-
Surabaya, East Java, IndonesiaDr. Soetomo General Hospital
Jun 21, 2023
Immunogenicity of Covid-19 Vaccination for Hematological
Active, not recruiting
- Immunogenicity
- +3 more
-
Varese, Lombardia, ItalyUOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
Sep 10, 2021
Brain Metastases, Adult, Neurocognitive Function, Cancer Trial in San Diego (Cognitive Sparing Brain Stereotactic Radiosurgery
Recruiting
- Brain Metastases, Adult
- +2 more
- Cognitive Sparing Brain Stereotactic Radiosurgery (SRS)
-
San Diego, CaliforniaMoores Cancer Center
May 17, 2022
Sputnik V Vaccine in Health Personnel of Private Effectors of
Completed
- COVID-19
-
Buenos Aires, Caba, ArgentinaHospital Italiano de Buenos Aires
Aug 24, 2021
COVID-19 Pandemic, COVID-19 Vaccines Trial in Jember, Malang, Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell
Recruiting
- COVID-19 Pandemic
- COVID-19 Vaccines
- Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
- CoronaVac Biofarma COVID-19 Vaccine
-
Jember, East Java, Indonesia
- +4 more
Aug 18, 2022
Hypertension, Mild Cognitive Impairment Trial in Atlanta (Candesartan, Lisinopril)
Completed
- Hypertension
- Mild Cognitive Impairment
-
Atlanta, GeorgiaEmory Univeristy
Feb 2, 2021
Precision Medicine in the Treatment of Epilepsy
Recruiting
- Epilepsy
- Levetiracetam
- +2 more
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Jan 6, 2023
Sleep Apnea, Obstructive, Hypertension Secondary Trial in Rio de Janeiro (Speech therapy, Control)
Unknown status
- Sleep Apnea, Obstructive
- Hypertension Secondary
- Speech therapy
- Control
-
Rio de Janeiro, BrazilHospital Universitário Clementino Fraga Filho
Nov 21, 2018
Aphasia, Stroke Trial in Birmingham (CIAT)
Completed
- Aphasia
- Stroke
- CIAT
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
May 10, 2018
Aphasia, Cerebrovascular Stroke Trial in Boston, Philadelphia (Transcranial Magnetic Stimulation, Repetitive)
Completed
- Aphasia
- Cerebrovascular Stroke
- Transcranial Magnetic Stimulation, Repetitive
-
Boston, Massachusetts
- +2 more
Dec 1, 2016
Meningococcal Meningitis Trial in Germany (MenACWY-CRM197 (two doses), MenC, PCV7)
Completed
- Meningococcal Meningitis
- MenACWY-CRM197 (two doses)
- +4 more
-
Bad Kreuznach, Germany
- +27 more
Sep 3, 2013